Daré Bioscience, Inc. (DARE)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.4348 |
| Open | 0.4299 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.4299 - 0.4899 |
| 52-week range | 0.2700 - 1.0200 |
| Volume | |
| Avg. volume | 718,484 |
| Market cap | 49.06M |
| Beta (5Y monthly) | 1.31 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3500 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.00 |
- Thomson Reuters StreetEvents
Q1 2024 Dare Bioscience Inc Earnings Call
Q1 2024 Dare Bioscience Inc Earnings Call
- GuruFocus.com
Dare Bioscience Inc (DARE) (Q1 2024) Earnings Call Transcript Highlights: Strategic Moves Amid ...
Explore key financial details, strategic initiatives, and forward-looking statements from Dare Bioscience's latest earnings call.
GlobeNewswireDaré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update
Conference Call and Webcast Today at 4:30 p.m. ETDevelopment Program Highlights and Anticipated 2024 Milestones Ovaprene® hormone-free monthly intravaginal contraceptive candidate pivotal Phase 3 contraceptive efficacy study recruiting across the United StatesSildenafil Cream, 3.6% topical formulation of sildenafil being developed to treat female sexual arousal disorder successful completion of end-of-Phase 2 meeting with FDA; forthcoming additional FDA feedback; Phase 3 design, development, and
© 2024 Yahoo. All rights reserved.